Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
Francesco Violi, Vittoria Cammisotto, Simona Bartimoccia, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 1, pp. 24-37
Open Access | Times Cited: 182

Showing 26-50 of 182 citing articles:

The therapeutic value of bifidobacteria in cardiovascular disease
Jia Tang, Yumeng Wei, Chao Pi, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Treatment with Ligilactobacillus murinus lowers blood pressure and intestinal permeability in spontaneously hypertensive rats
Masashi Mukohda, Takanori Yano, Toshiyasu Matsui, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
The sweet corn cob selenium polysaccharide alleviates type 2 diabetes via modulation of LPS/IκBα/NFκB and the intestinal microbiota
Jingyang Wang, Xin Wang, Weiye Xiu, et al.
Food Bioscience (2024) Vol. 58, pp. 103742-103742
Closed Access | Times Cited: 7
Ginsenosides retard atherogenesis via remodelling host–microbiome metabolic homeostasis
Yun Wang, Jiawei Wu, Yu Hong, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 12, pp. 1768-1792
Closed Access | Times Cited: 6
Unraveling the Role of the Human Gut Microbiome in Health and Diseases
Mohamad Khalil, Agostino Di Ciaula, Laura Mahdi, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2333-2333
Open Access | Times Cited: 6
Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review
Eline Birkeland, Sedegheh Gharagozlian, Jørgen Valeur, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Targeting the GLP-2 receptor in the management of obesity
Thorir G. Pálsson, Hannah Gilliam-Vigh, Benjamin A. H. Jensen, et al.
Peptides (2024) Vol. 177, pp. 171210-171210
Open Access | Times Cited: 5
Oleuropein, a Component of Extra Virgin Olive Oil, Improves Liver Steatosis and Lobular Inflammation by Lipopolysaccharides–TLR4 Axis Downregulation
Leonardo Schirone, Diletta Overi, Guido Carpino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5580-5580
Open Access | Times Cited: 5
Limosilactobacillus fermentum HNU312 alleviates lipid accumulation and inflammation induced by a high-fat diet: improves lipid metabolism pathways and increases short-chain fatty acids in the gut microbiome
Jiahe Li, Zeng Zhang, Yuan Xu, et al.
Food & Function (2024) Vol. 15, Iss. 17, pp. 8878-8892
Closed Access | Times Cited: 5
Elevated LPS is largely driven by time since symptom onset in acute ischemic stroke: the impact on clinical outcomes
Michał Błaż, Joanna Natorska, Jan Bembenek, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 11, pp. 3161-3171
Closed Access | Times Cited: 5
The Yin and Yang of TLR4 in COVID-19
Suprabhat Mukherjee, Jagadeesh Bayry
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 5
Causal Association between the Gut Microbiota and Chronic Kidney Disease: A Two-Sample Mendelian Randomization Study in a Chinese Population
Wenjian Lin, Zixin Liang, Junxuan Fang, et al.
(2025)
Closed Access
Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis
Quinten J. J. Augustijn, Aldo Grefhorst, Pleun de Groen, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e088290-e088290
Open Access
The gut microbiota and its role in the development of cardiovascular disease
Carlos Escobar, Xavier Aldeguer, David Vivas, et al.
Expert Review of Cardiovascular Therapy (2025), pp. 1-12
Closed Access
Senile Osteoarthritis Regulated by the Gut Microbiota: From Mechanisms to Treatments
Yu Fan, Chenyu Zhu, Wei Wu
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1505-1505
Open Access
Periodontitis-related myocardial fibrosis by expansion of collagen-producing SiglecF+ neutrophils
Xuekui Wang, Yue Xu, Canqing Yu, et al.
European Heart Journal (2025)
Closed Access
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Exploring Systemic Impacts and Innovative Therapies
Parag Jain, Akanksha Jain, Rohitas Deshmukh, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102584-102584
Closed Access
The impact of bacterial infection on the risk of portal vein thrombosis development in patients with cirrhosis: A post-hoc analysis
Simone Di Cola, Jakub Gazda, Stefano Fonte, et al.
Digestive and Liver Disease (2025)
Open Access
An association between poor oral health, oral microbiota, and pain identified in New Zealand women with central sensitisation disorders: a prospective clinical study
Sharon Erdrich, Ingrid C. Gelissen, Momchilo Vuyisich, et al.
Frontiers in Pain Research (2025) Vol. 6
Open Access
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets
Angelo Silverio, Francesco Paolo Cancro, Luca Esposito, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2161-2161
Open Access | Times Cited: 12
Gut dysbiosis-derived low-grade endotoxemia: A common basis for liver and cardiovascular disease
Francesco Violi, Cristina Nocella, Simona Bartimoccia, et al.
Kardiologia Polska (2023) Vol. 81, Iss. 6, pp. 563-571
Open Access | Times Cited: 12
The Systemic Immune Inflammatory Response Index Can Predict the Clinical Prognosis of Patients with Initially Diagnosed Coronary Artery Disease
Yuqing Li, Geng Bai, Yi Gao, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5069-5082
Open Access | Times Cited: 12
Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation
Leon Blöbaum, Marco Witkowski, Max Wegner, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 176-176
Open Access | Times Cited: 11
Exertional Stress-induced Pathogenic Luminal Content Translocation – Friend or Foe?
Kayla Henningsen, Isabel G. Martinez, Ricardo J. S. Costa
International Journal of Sports Medicine (2024) Vol. 45, Iss. 08, pp. 559-571
Closed Access | Times Cited: 4
Intestinal mucosal barrier: a potential target for traditional Chinese medicine in the treatment of cardiovascular diseases
Jiahui Liu, Xiunan Wei, Tong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4

Scroll to top